Detalhe da pesquisa
1.
Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone.
EMBO Rep
; 21(6): e50162, 2020 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32314873
2.
Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer.
Cancer Immunol Immunother
; 70(8): 2125-2138, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33449132
3.
A niche-dependent myeloid transcriptome signature defines dormant myeloma cells.
Blood
; 134(1): 30-43, 2019 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31023703
4.
AlphaBet: Combination of Radium-223 and [17 7Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol).
Front Med (Lausanne)
; 9: 1059122, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36465905
5.
Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer.
Cancer Res Commun
; 2(7): 706-724, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36923279
6.
Intratumoral administration of the Toll-like receptor 7/8 agonist 3M-052 enhances interferon-driven tumor immunogenicity and suppresses metastatic spread in preclinical triple-negative breast cancer.
Clin Transl Immunology
; 9(9): e1177, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33005415
7.
Beyond the vicious cycle: The role of innate osteoimmunity, automimicry and tumor-inherent changes in dictating bone metastasis.
Mol Immunol
; 110: 57-68, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29191489
8.
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression.
Cancers (Basel)
; 11(12)2019 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31842362
9.
Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC.
NPJ Precis Oncol
; 3: 21, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31482136
10.
Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBC.
Cancer Immunol Res
; 5(10): 871-884, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28848054